Welcome on board, Ian Henion!We are pleased to announce that Ian Henion has joined Myro as a Research Associate. Ian joins us from Cell Signaling Technology and will be a very valuable addition to the neuroscience team!November 1, 2023
Welcome on board, Christie Blake!We are pleased to welcome Christie Blake to Myro. Christie joins us from Valerio Therapeutics and will be a very valuable addition to the team!October 23, 2023
Welcome on board, Tengfei Xue!We are pleased to announce that Tengfei Xue has joined Myro as a Scientist. Tengfei joins us from Simcere Pharmaceuticals. He will be a valuable addition to our Neuroscience team!October 16, 2023
Welcome on board, Debarun Gupta!We are excited to announce that Debarun Gupta has joined Myro as Head of Business Development. Debarun joins us from FibroGen and will be a very valuable addition to the team!September 18, 2023
Myro Celebrates its 2nd Anniversary!Myro's Boston team celebrated its 2nd Anniversary with a cooking class at the Cambridge School of Culinary Arts.July 31, 2023
Welcome on board, Julian Vasquez!We are excited to welcome Julian Vasquez to the operations unit at Myro. Julian joins us from Codiak Biosciences and will be a great addition to the team!July 10, 2023
Myro selected to participate in WIB’s Annual Lobster Pot Pitch event during BIO 2023!We are excited to announce that Myrobalan Therapeutics has been selected as a participant in the WIB’s Greater Boston Annual Lobster Pot Pitch Event to be held during BIO 2023. June 5, 2023
Myro Wins First Place in International Biotech Start-up Pitch CompetitionMyro is thrilled to announce its first-place win in the 2023 International Biotech Start-up Pitch Competition hosted by the Boston Chinese Investment Club (BCIC).May 15, 2023
Myrobalan Therapeutics Nanjing Co. LTD announced residency at JLABS @ Shanghai Nanjing, China, May 4, 2023 – Myrobalan Therapeutics Nanjing Co. LTD (‘Myro’) announced today that, effective April 10, 2023, it has become a resident of Johnson & Johnson Innovation – JLABS @ Shanghai (‘JLABS’).May 4, 2023
Myro chosen as a finalist for the BCIC 2023 Biomedical Pitch Competition!We are excited to announce that Myrobalan Therapeutics has been selected as a finalist for the 2023 Biomedical Pitch Competition for the Boston Chinese Investment Club to be held on April 29th! You can register using the following link to attend this event online for free: https://www.eventbrite.com/e/2023-biomedical-conference-tickets-580446921367.April 10, 2023
Happy International Women's Day!Myro celebrated International Women's Day today at our new offices at 200 Boston Avenue. March 8, 2023
Myro Therapeutics has a new address!We moved into our newly designed space at 200 Boston Avenue in Medford this month.December 19, 2022
Welcome on board, Nora Lin!We are excited to welcome Nora Lin to the Myro team. Nora joins us from Bristol-Myers Squibb and will be a valuable addition to the team.November 8, 2022
Myro celebrates 1 year anniversary!Myro celebrated its first year as a company in August, and we held a luncheon meeting this month to review our accomplishments this first year.October 20, 2022
Welcome on board, Michael Young!We are excited to welcome Michael Young to the Neuropharmacology unit at Myro. Michael joins us from Duke University and will be a great addition to the team!September 26, 2022
Welcome on board, Karen Smith!We are excited to announce that Karen Smith has joined Myro as Program Lead. Karen brings more than 20 years of pharma/biotech experience to our company and will be a very valuable addition to the team.September 12, 2022
Welcome on board, Shannon Wheeler!We are excited to welcome Shannon Wheeler to the Myro team. Shannon joins us from the University of Illinois at Chicago and will be a valuable addition to the Neuropharmacology Unit.August 8, 2022
Myro Therapeutics has a new address!We moved into our new space at 155 Arlington Street in Watertown this month and celebrated with a company-wide luncheon.May 5, 2022
Welcome on board, Nathan Parker!We are excited to welcome Nathan Parker to the Neuropharmacology unit at Myro. Nathan joins us from Rockefeller University. Prior to that he attended Michigan State University for his BS and received his PhD from Princeton University. Nathan will be a great addition to the team!April 4, 2022
Welcome on Board, Bolin Geng!We are very excited to announce that Bolin Geng has joined Myro as the Head of Medicinal Chemistry. Bolin brings to Myro more than 25 years of drug development experience which will be of tremendous help to advance our program. Bolin joined Myro from LEAF4Life. Prior to that he had worked in the pharma industry, including 10 years at AstraZeneca. Bolin received his PhD from University of Montpellier.March 14, 2022
